Cargando…
Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis
INTRODUCTION: Aortic arch calcification (AoAC) is related closely to mortality risk in patients undergoing maintenance dialysis. Recent experimentally obtained data suggest that osteoprotegerin/receptor activator for nuclear factor κB ligand signal transmission plays a role in de novo chondrogenic t...
Autores principales: | Suzuki, Shunji, Suzuki, Makoto, Hanafusa, Norio, Tsuchiya, Ken, Nitta, Kosaku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938059/ https://www.ncbi.nlm.nih.gov/pubmed/33732975 http://dx.doi.org/10.1016/j.ekir.2020.12.002 |
Ejemplares similares
-
Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
por: Suzuki, Shunji, et al.
Publicado: (2018) -
Gelsolin and Progression of Aortic Arch Calcification in Chronic Hemodialysis Patients
por: Chiou, Terry Ting-Yu, et al.
Publicado: (2016) -
Progression of Aortic Arch Calcification Is Associated with Overall and Cardiovascular Mortality in Hemodialysis
por: Chung, Wei-Shiuan, et al.
Publicado: (2020) -
Association of aortic arch and aortic valve calcifications with cardiovascular risk in patients on maintenance hemodialysis
por: Liao, Min-Tser, et al.
Publicado: (2022) -
Aortic Arch Calcification and Cardiomegaly Are Associated with Overall and Cardiovascular Mortality in Hemodialysis Patients
por: Ou, Shih-Hsiang, et al.
Publicado: (2021)